ATE195876T1 - Reinigung einer den müller-mischtumor inhibierenden substanz und behandlung von einigen tumoren - Google Patents

Reinigung einer den müller-mischtumor inhibierenden substanz und behandlung von einigen tumoren

Info

Publication number
ATE195876T1
ATE195876T1 AT92917403T AT92917403T ATE195876T1 AT E195876 T1 ATE195876 T1 AT E195876T1 AT 92917403 T AT92917403 T AT 92917403T AT 92917403 T AT92917403 T AT 92917403T AT E195876 T1 ATE195876 T1 AT E195876T1
Authority
AT
Austria
Prior art keywords
treatment
tumors
müller
purification
substance inhibiting
Prior art date
Application number
AT92917403T
Other languages
English (en)
Inventor
Patricia K Donahoe
Taiwai Chin
Robert L Parry
James Epstein
Richard C Ragin
David T Maclaughlin
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE195876T1 publication Critical patent/ATE195876T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92917403T 1991-04-12 1992-04-13 Reinigung einer den müller-mischtumor inhibierenden substanz und behandlung von einigen tumoren ATE195876T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68396691A 1991-04-12 1991-04-12
PCT/US1992/003041 WO1992018152A1 (en) 1991-04-12 1992-04-13 Use of müllerian inhibiting substance for treatment of certain tumors

Publications (1)

Publication Number Publication Date
ATE195876T1 true ATE195876T1 (de) 2000-09-15

Family

ID=24746176

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92917403T ATE195876T1 (de) 1991-04-12 1992-04-13 Reinigung einer den müller-mischtumor inhibierenden substanz und behandlung von einigen tumoren

Country Status (7)

Country Link
EP (1) EP0584287B1 (de)
JP (1) JPH06510022A (de)
AT (1) ATE195876T1 (de)
AU (1) AU1799392A (de)
CA (1) CA2108264A1 (de)
DE (1) DE69231403T2 (de)
WO (1) WO1992018152A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661126A (en) * 1989-01-19 1997-08-26 The General Hospital Corporation Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression
WO1994000133A1 (en) * 1992-06-19 1994-01-06 The General Hospital Corporation Use of mullerian inhibiting substance for treating tumors and for modulating class 1 major histocompatibility antigen expression
WO2004017919A2 (en) * 2002-08-23 2004-03-04 The General Hospital Corporation Use of mullerian inhibiting substance and interferon for treating tumors
WO2008116161A2 (en) 2007-03-22 2008-09-25 The General Hospital Corporation Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states
WO2009012357A2 (en) 2007-07-17 2009-01-22 The General Hospital Corporation Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4510131A (en) * 1981-07-29 1985-04-09 The General Hospital Corporation Purified Mullerian Inhibiting Substance and method of use
US4487833A (en) * 1982-03-01 1984-12-11 The General Hospital Corporation Method of preparing hybridomas and of purifying immunogenic materials
EP0169645A1 (de) * 1984-06-27 1986-01-29 Johnson Matthey Public Limited Company Platin-Koordinationsverbindungen
US5310880A (en) * 1991-04-12 1994-05-10 The General Hospital Corporation Purification of Mullerian inhibiting substance

Also Published As

Publication number Publication date
EP0584287A4 (en) 1994-07-20
CA2108264A1 (en) 1992-10-13
DE69231403T2 (de) 2001-02-08
EP0584287A1 (de) 1994-03-02
WO1992018152A1 (en) 1992-10-29
JPH06510022A (ja) 1994-11-10
EP0584287B1 (de) 2000-08-30
DE69231403D1 (de) 2000-10-05
AU1799392A (en) 1992-11-17

Similar Documents

Publication Publication Date Title
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
RU93048466A (ru) Применение бензотиофенов для профилактики и лечения остеопороза и фармацевтическая композиция на их основе
BR9805544A (pt) Uso de um composto.
BG101118A (en) Therapeutical compounds
ATE203019T1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane
ATE234088T1 (de) Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
EP0709090A3 (de) Zusammensetzungen zur Behandlung von resistenten Tumoren
EP1001782A4 (de) 5,6-HETEROARYL-DIPYRIDO (2-3-b:3',2'-f) AZEPINE UND DEREN VERWENDUNG ZUR PROPHYLAXE UND BEHANDLUNG VON HIV-INFEKTIONEN
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
ATE199167T1 (de) Nichtglykosyliertes fgf-4 und dieses enthaltende präparate
EP0601058A4 (de) Transdermale formulierungen zur prazosinverabreichung.
ATE158183T1 (de) Arzneimittel zur behandlung von anxietas
ZA947957B (en) Substituted 1-naphthyl-3-pyrazolecarboxamides which are active in neurotensin their preparation and pharmaceutical compositions containing them
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
PL313078A1 (en) Novel bis-naphtalimides for use in treating carcinoma
RU2001124802A (ru) Применение саредутанта и его фармацевтически приемлемых солей для приготовления лекарственных средств, применяемых для лечения или предупреждения расстройств настроения, расстройств адаптации или смешанных тревожно-депрессивных расстройств
ATE195876T1 (de) Reinigung einer den müller-mischtumor inhibierenden substanz und behandlung von einigen tumoren
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
BR9712307A (pt) Pirazolinonas para o tratamento de potência enfraquecida
ATE159171T1 (de) Arzneimittelzusammensetzung enthaltend tcf-ii
IE792418L (en) Diazines.
DK0510913T3 (da) Farmaceutiske sammensætninger indeholdende calcitonin